Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 3/20 | 0.56 |
| ▸ | MAOB | P27338 | 3/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | CTRC | Q99895 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.47 |
| ▸ | AHR | P35869 | 2/20 | 0.46 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.45 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | RHEB | Q15382 | 1/20 | 0.42 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9474836 | 1.00 | MAOA (0.56) | MAOAMAOBCYP1A2MEN1KMT2A | |
| SCHEMBL9475224 | 0.91 | MAOA (0.64) | MAOAMAOBCYP1A2MEN1KMT2A | |
| SCHEMBL481976 | 0.91 | MAOA (0.64) | MAOAMAOBCYP1A2MEN1KMT2A | |
| SCHEMBL9476350 | 0.91 | MAOA (0.64) | MAOAMAOBCYP1A2MEN1KMT2A | |
| SCHEMBL10534271 | 0.90 | CYP1A2 (0.71) | MAOAMAOBCYP1A2MEN1KMT2A | |
| SCHEMBL6546576 | 0.88 | MAOA (0.61) | MAOAMAOBCYP1A2MEN1KMT2A | |
| SCHEMBL6546581 | 0.88 | MAOA (0.61) | MAOAMAOBCYP1A2MEN1KMT2A | |
| SCHEMBL28432241 | 0.86 | MAOA (0.50) | MAOAMAOBCYP1A2MEN1KMT2A | |
| Biphenyl SCHEMBL17985318 | 0.83 | CYP1A2 (0.61) | MAOAMAOBCYP1A2MEN1KMT2A | |
| SCHEMBL944439 | 0.82 | CYP1A2 (0.52) | MAOAMAOBCYP1A2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9469604-B2 | Method of manufacturing sulfonium salt | TOYO GOSEI CO., LTD. (JP) | 2016-10-18 | — | — | US | claimed |
| US-9469604-B2 | Method of manufacturing sulfonium salt | TOYO GOSEI CO., LTD. (JP) | 2016-10-18 | — | — | US | disclosed |
| US-20160068477-A1 | METHOD OF MANUFACTURING SULTONIUM SALT | TOYO GOSEI CO., LTD. (JP) | 2016-03-10 | — | — | US | disclosed |
| US-7709548-B2 | Method for manufacturing monosulfonium salt, cationic polymerization initiator, curable composition, and cured product | SAN-APRO LIMITED (JP) | 2010-05-04 | — | — | US | disclosed |
| US-20090163723-A1 | METHOD FOR PRODUCING SULFONIUM FLUORINATED ALKYLFLUOROPHOSPHATE | SAN-APRO LIMITED (JP) | 2009-06-25 | — | — | US | disclosed |
| US-7442459-B2 | Solid electrolyte, membrane and electrode assembly, and fuel cell | FUJIFILM CORPORATION (JP) | 2008-10-28 | — | — | US | disclosed |
| US-20080249270-A1 | Method for manufacturing monosulfonium salt, cationic polymerization initiator, curable composition, and cured product | DATE MASASHI | 2008-10-09 | — | — | US | disclosed |
| EP-1953139-A1 | METHOD FOR PRODUCING FLUORINATED SULFONIUM ALKYLFLUOROPHOSPHATE | San-Apro Ltd. (JP) | 2008-08-06 | — | — | EP | disclosed |
| EP-1350789-B1 | PROCESS FOR PRODUCING SULFONIUM SALT | SAN APRO LTD (JP) | 2008-06-25 | — | — | EP | disclosed |
| US-20080108720-A1 | Method for manufacturing monosulfonium salt, cationic polymerization initiator, curable composition, and cured product | DATE MASASHI | 2008-05-08 | — | — | US | disclosed |
| EP-1640363-B1 | PROCESS FOR PRODUCTION OF MONOSULFONIUM SALTS, CATIONIC POLYMERIZATION INITIATORS, CURABLE COMPOSITIONS, AND PRODUCTS OF CURING | SAN APRO LTD (JP) | 2008-01-16 | — | — | EP | disclosed |
| US-20060247401-A1 | Process for production of monosulfonium salts, cationic polymerization initiators, curable compositions, and products of curing | SAN-APRO LIMITED (JP) | 2006-11-02 | — | — | US | disclosed |
| US-7060858-B2 | Method for manufacturing sulfonium salts | SAN-APRO LIMITED (JP) | 2006-06-13 | — | — | US | disclosed |
| EP-1640363-A1 | PROCESS FOR PRODUCTION OF MONOSULFONIUM SALTS, CATIONIC POLYMERIZATION INITIATORS, CURABLE COMPOSITIONS, AND PRODUCTS OF CURING | San-Apro Limited (JP) | 2006-03-29 | — | — | EP | disclosed |
| US-20040030158-A1 | Method for manufacturing sulfonium salts | SAN-APRO LIMITED (JP) | 2004-02-12 | — | — | US | disclosed |
| EP-1350789-A1 | PROCESS FOR PRODUCING SULFONIUM SALT | San-Apro Limited (JP) | 2003-10-08 | — | — | EP | disclosed |
| US-4248795-A | BY OXIDATION OF THE CORRESPONDING SULFIDE WITH AN AQUEOUS PERACID SOLUTION | UNION CARBIDE CORPORATION (US) | 1981-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060247401-A1 | Process for production of monosulfonium salts, cationic polymerization initiators, curable compositions, and products of curing | RPS6, SPIN4, SRM | MAOA 3278/4885MAOB 3263/4885CYP1A2 3904/4885 |
| US-20040030158-A1 | Method for manufacturing sulfonium salts | MLX, STS, SULT1A1 | MAOA 831/4885MAOB 851/4885CYP1A2 80/4885 |
| US-20090163723-A1 | METHOD FOR PRODUCING SULFONIUM FLUORINATED ALKYLFLUOROPHOSPHATE | ARSA, SCO2, DOHH | MAOA 2326/4885MAOB 2031/4885CYP1A2 583/4885 |
| US-20080108720-A1 | Method for manufacturing monosulfonium salt, cationic polymerization initiator, curable composition, and cured product | SPIN4, RPS6, SRM | MAOA 3349/4885MAOB 3254/4885CYP1A2 4180/4885 |
| US-20080249270-A1 | Method for manufacturing monosulfonium salt, cationic polymerization initiator, curable composition, and cured product | SPIN4, RPS6, SRM | MAOA 3349/4885MAOB 3254/4885CYP1A2 4180/4885 |
| US-20160068477-A1 | METHOD OF MANUFACTURING SULTONIUM SALT | STS, SULT1A1, ARSA | MAOA 4760/4885MAOB 4672/4885CYP1A2 1424/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.